[Pharmacokinetic and clinical research on a new aminoglycoside antibiotic: sisomicin]

Minerva Med. 1978 Sep 19;69(43):2951-62.
[Article in Italian]

Abstract

Results obtained with sisomycin in 10 cases of purulent meningitis and 4 of bronchopulmonitis showed good tissue diffusion, together with CSF concentrations sufficient to inhibit the main aetiological agents in these forms: MIC 0.02 mg/ml for both D. pneumoniae (I-ATCC 6301) and N. meningitidis (C-ATCC 13101), i.e. liquor transfer of the antibiotic more than sufficient to handle these agents.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Bacteria / drug effects
  • Bronchopneumonia / drug therapy*
  • Child
  • Drug Evaluation
  • Female
  • Gentamicins / therapeutic use*
  • Humans
  • Injections, Intramuscular
  • Injections, Intravenous
  • Male
  • Meningitis / drug therapy*
  • Meningococcal Infections / drug therapy*
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pneumococcal Infections / drug therapy*
  • Sisomicin / adverse effects
  • Sisomicin / metabolism
  • Sisomicin / therapeutic use*

Substances

  • Gentamicins
  • Sisomicin